Search Ontology:
ChEBI
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
- Term ID
- CHEBI:65239
- Synonyms
-
- (1->3)-(1->6)-mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitor
- (1->3)-(1->6)-mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitors
- 1,3(1,6)-alpha-D-mannosidase inhibitor
- 1,3(1,6)-alpha-D-mannosidase inhibitors
- 1,3-(1,6-)mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitor
- 1,3-(1,6-)mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitors
- alpha-D-mannosidase II inhibitor
- alpha-D-mannosidase II inhibitors
- alpha-mannosidase II inhibitor
- alpha-mannosidase II inhibitors
- alpha1-3,6-mannosidase inhibitor
- alpha1-3,6-mannosidase inhibitors
- EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitors
- EC 3.2.1.114 inhibitor
- EC 3.2.1.114 inhibitors
- exo-1,3-1,6-alpha-mannosidase inhibitor
- exo-1,3-1,6-alpha-mannosidase inhibitors
- GlcNAc transferase I-dependent alpha1,3[alpha1,6]mannosidase inhibitor
- GlcNAc transferase I-dependent alpha1,3[alpha1,6]mannosidase inhibitors
- golgi alpha-mannosidase II inhibitor
- golgi alpha-mannosidase II inhibitors
- ManII inhibitor
- ManII inhibitors
- mannosidase II inhibitor
- mannosidase II inhibitors
- mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (EC 3.2.1.114) inhibitor
- mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (EC 3.2.1.114) inhibitors
- mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase inhibitor
- mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase inhibitors
- Definition
- An enzyme inhibitor that interferes with the action of mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (EC 3.2.1.114), a key enzyme target in the development of anti-cancer therapies.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse has_role
-
Phenotype
Phenotype resulting from EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
Phenotype where environments contain EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
Phenotype modified by environments containing EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
Human Disease Model